Ennature Biopharma
Trending Articles
Related Content
Research & Development
Peer-reviewed randomised controlled trial demonstrates clinical efficacy of Maxicuma for joint health
A newly published randomised controlled trial published in the European Journal of Integrative Medicine confirms that Maxicuma, Ennature Biopharma’s proprietary curcumin formulation developed using proprietary LIMAN™ technology, demonstrated significant improvements in pain intensity, mobility and function compared to placebo